In a surprising finding using the standard animal model of Down syndrome (DS), scientists were able to correct the learning and memory deficits associated with the condition the leading genetic cause of cognitive disability and the most frequently diagnosed chromosomal disorder in the U.S. with drugs that target the bodys response to cellular stresses.
In a study published Nov. 14, 2019, in the journal Science, a team led by researchers at UC San Francisco and Baylor College of Medicine show that some of the intellectual impairments associated with DS may be traced to altered protein production in a region of the brain called the hippocampus, which is central to learning and long-term memory formation.
But in the so-called Ts65Dn mouse, engineered to capture genetic, behavioral and cognitive features of human Down syndrome, these changes can be undone. When the researchers administered drugs that target one of the cells key stress response pathways, they were able to bring protein levels back to normal, which caused the cognitive deficits typical of the Ts65Dn mouse to vanish.
Although the cognitive features of DS have generally been thought of as irreversible, the researchers say, these findings indicate that it may be possible to improve cognitive function in human DS using similar compounds.
Because DS is caused by an extra copy of chromosome 21, scientists have generally studied the disease through the lens of genetics, focusing primarily on ways in which the superfluous chromosome disrupts normal gene activity. But in the new study, rather than restricting their efforts to genes and chromosomes, the scientists trained their sights on the largely unexplored role of proteostasis a technical term for the cells protein manufacturing and quality control machinery in DS.
Peter Walter, Ph.D., co-senior author of the study, spearheaded the research to uncover a link between proteostasis defects and DS.
The vast majority of the field has been focusing on individual genes on chromosome 21 to figure out which ones are causally related to Down syndrome and its pathologies. Our approach was different. We were trying to uncover a link between proteostasis defects and DS, said Peter Walter, Ph.D., professor of Biochemistry and Biophysics at UCSF and co-senior author of the new study.
Walter spearheaded the new study with collaborator Mauro Costa-Mattioli, Ph.D., a professor of neuroscience at Baylor College of Medicine who is currently a visiting professor in Walters lab thanks to a UCSF Presidential Chair Award.
To identify proteostasis problems that might contribute to DS, the researchers turned to a common mouse model that captures most of the chromosomal, developmental and cognitive abnormalities that define the human version of the syndrome.
Using polysome profiling, a technique that allows scientists to take a detailed snapshot of the cells protein factories in action, the researchers found that up to 39 percent less protein was being produced in the hippocampus of DS mice, prompting them to ask why extra copies of genes could lead to a decline in protein production.
The researchers discovered that hippocampal cells in DS mice had activated whats known as the integrated stress response (ISR), a biological circuit that detects when somethings awry the presence of an extra chromosome, for example, in the case of DS and engages a protective response that activates machinery to tamp down protein production.
The cell is constantly monitoring its own health. When something goes wrong, the cell responds by making less protein, which is usually a sound response to cellular stress. But you need protein synthesis for higher cognitive functions, so when protein synthesis is reduced, you get a pathology of memory formation, said Walter.
Backing up these results, the scientists also found that the ISR was also activated in postmortem samples of brain tissue from people with DS. And by a stroke of pure luck, the researchers were able to obtain a tissue sample from a person with DS in whom some cells carried the expected third copy of chromosome 21, while others were genetically normal the ISR, however, was only active in the cells with the extra chromosome.
Taken together, these findings strongly suggest that the ISR is involved in, and perhaps even responsible for, certain DS symptoms.
Though the ISR can be activated by four different enzymes, the scientists found that only one of them, named PKR, was involved in activating the ISR in hippocampal cells in DS. By blocking the activity of PKR they were able to prevent ISR activation and reverse the declines in protein production that had been observed in the brains of DS mice. But even more impressive, the researchers found that blocking the ISR significantly improved cognitive function in these mice as well.
The researchers used three different approaches to dial down ISR activity deleting the PKR gene, using a drug that suppresses PKR activity, and finally, using a safe, well-studied drug called ISRIB that activates protein-manufacturing machinery that competes directly with the ISRs efforts to shut off protein production. All three approaches yielded a marked improvement in cognition, as demonstrated by two different memory and learning tests.
We started with a situation that looked hopeless, nobody thought anything could be done. But we may have struck gold.Peter Walter, Ph.D.
Importantly, these changes were physiological as well as behavioral. DS mice that were given ISR inhibitors showed improved function at synapses, sites between nerve cells where changes associated with learning take place. In fact, after ISR activity was blocked, the brains of DS mice were transmitting fewer of the inhibitory signals that can make it harder for the brain to learn and form new long-term memories.
Though the results of the study were extremely promising, Walter cautions that much more in this area remains to be studied. Still, the findings are an important first step toward finding therapies that could improve the lives and overall health of people living with DS, a condition that has generally been considered untreatable.
We started with a situation that looked hopeless, Walter said. Nobody thought anything could be done. But we may have struck gold.
Authors: Additional authors include Ping Jun Zhu, Sanjeev Khatiwada, Ya Cui, Lucas C. Reineke, Sean W. Dooling, Jean J. Kim, and Wei Li of the Baylor College of Medicine. Peter Walter is also a Howard Hughes Medical Institute investigator.
Funding: This study was funded by NIH grants R01NS076708, R01HG007538, R01CA193466 and R01 CA228140, Sammons Enterprises and the Howard Hughes Medical Institute.
Disclosures: Peter Walter is an inventor on U.S. Patent 9708247 held by the Regents of the University of California that describes ISRIB and its analogs. Rights to the invention have been licensed by UCSF to Calico LLC. Wei Li is a consultant for the Chosen Med. The authors declare no other competing interests.
See more here:
- The genetic architecture of the human cerebral cortex - Science Magazine - March 26th, 2020
- The Coronavirus Pandemic Shows Us The Importance Of Combatting Climate Change - Forbes - March 26th, 2020
- Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis - P&T... - March 26th, 2020
- IN CONSERVATION: DR. JEFF STROVEL, CEO of VERALOX THERAPEUTICS - BioBuzz - March 26th, 2020
- How healthtech startup Bione aims to use genetic testing in the fight against coronavirus - YourStory - March 26th, 2020
- Coronavirus: Massive gap in US response revealed after scientists learn colleague tested positive through twee - MEAWW - March 26th, 2020
- Avera announces ability to test for COVID-19 in South Dakota - The Dickinson Press - March 24th, 2020
- University of Utah experts advise caution over drugs hyped as possible coronavirus treatments - Salt Lake Tribune - March 24th, 2020
- Invitae and Muscular Dystrophy Association (MDA) Expand Access to No-Charge Genetic Testing in the US and Canada - PRNewswire - March 24th, 2020
- Studying the African genome could yield new medical treatments for everyone - Genetic Literacy Project - March 24th, 2020
- Human Genetics Market Higher Growth Rate / CAGR over the Forecast Period to 2026 by Key Players like QIAGEN, Agilent Technologies, Illumina - New Day... - March 16th, 2020
- Coronavirus is hard on older people and scientists aren't sure why - NBCNews.com - March 16th, 2020
- Researchers study irregular horse heartbeats, hoping to find a cure - Minnesota Daily - March 16th, 2020
- Dr. John T. Macdonald Foundation seeking to fund community-based organizations with major grant dollars - Miami's Community Newspapers - March 16th, 2020
- A book that could save lives: Adam Rutherford's How to Argue with a Racist reviewed - Spectator.co.uk - March 16th, 2020
- Validea's Top Five Healthcare Stocks Based On Motley Fool - 3/15/2020 - Nasdaq - March 16th, 2020
- Fighting the coronavirus outbreak with genetic sequencing, CRISPR and synthetic biology - Genetic Literacy Project - March 16th, 2020
- human genetics | Description, Chromosomes, & Inheritance ... - February 29th, 2020
- Human Genetics | Pitt Public Health | University of Pittsburgh - February 29th, 2020
- Amgen To Present At The Cowen 40th Annual Healthcare Conference - BioSpace - February 29th, 2020
- Working on 'the human side' of heritable cancers - Penn: Office of University Communications - February 29th, 2020
- Ancient Scotsman with Protruding Rear End Found Carved on Monolith - The Vintage News - February 29th, 2020
- Her parents taught her grit, caring for others. She's using those traits to fight heart disease. - Thrive Global - February 29th, 2020
- IFFGD Raises Awareness for Rare Digestive Diseases on Rare Disease Day 2020 - P&T Community - February 29th, 2020
- Research on intermittent fasting shows health benefits - National Institute on Aging - February 29th, 2020
- When a Supervolcano Erupted, These Ancient People Survived the Blankets of Ash - Discover Magazine - February 29th, 2020
- Why This S&P 500 Stock Is Defying the Brutal Coronavirus Plunge - CCN.com - February 29th, 2020
- Stone tools show humans in India survived the cataclysmic Toba eruption 74,000 years ago - Firstpost - February 29th, 2020
- Scientist Who Discovered BRCA1 Gene to Give Free Talk on Cancer And Genetics - Noozhawk - January 19th, 2020
- Genetic testing firm 23andMe is first to create a drug using its customers' DNA - The Times - January 19th, 2020
- Hackensack Meridian Health Center for Discovery and Innovation to Host Genomic Medicine Symposium - P&T Community - January 19th, 2020
- 11 Year-Old Bertrand Might Cant Cry Scientists Have Now Discovered Why - SciTechDaily - January 19th, 2020
- Transposons Identified as Likely Cause of Undiagnosed Diseases - The Scientist - January 19th, 2020
- Do genetic ancestry tests know if you're Palestinian? A cautionary tale of race and science - ABC News - January 19th, 2020
- Controlling Our Own Evolution: What is the Future of Gene-Editing? - The Globe Post - January 19th, 2020
- There is a new player in adult bone healing - Baylor College of Medicine News - January 19th, 2020
- Air Pollution, Evolution, and the Fate of Billions of Humans - The New York Times - January 19th, 2020
- A New York Times column on 'Jewish genius' draws criticism for linking to a debunked University of Utah study - Salt Lake Tribune - January 5th, 2020
- Ambroxol Reverses Bone Damage in Girl With GD Type 1, Case Study Shows - Gaucher Disease News - January 5th, 2020
- Gene editing breakthroughs that cured genetic diseases in 2019 - The Star Online - January 5th, 2020
- Digid8 and the Emergence of DNA Matchmaking - Study Breaks - January 5th, 2020
- Etched in DNA: Decoding the secrets of the past - Christian Science Monitor - January 5th, 2020
- The Face of Science - Clemson World magazine - January 5th, 2020
- Aborting Babies Because They're Gay: Coming Soon to China - Patheos - January 5th, 2020
- Mutants among us: "Natural short sleepers" reveal the genetics of sleep - Inverse - January 5th, 2020
- The End of Infertility Is in Sight - UCSF News Services - January 5th, 2020
- Who is a Jew? DNA home testing adds new wrinkle to age-old debate - The Jewish News of Northern California - December 1st, 2019
- Humans and autoimmune diseases continue to evolve together - Medical News Today - December 1st, 2019
- Mutations in emerging autism gene tied to distinct traits - Spectrum - December 1st, 2019
- Gail Fisher's 'Dog Tracks': Spoiling you dog with extra food could cut short its life - The Union Leader - December 1st, 2019
- In a Wisconsin village, the doctor makes house calls and sees the rarest diseases on Earth - USA TODAY - December 1st, 2019
- Alzheimer's and Autism: Researchers Pinpoint Genetic Mutations Overlapping in Both Diseases - Being Patient - December 1st, 2019
- How do consumer DNA tests from the US and China stack up? - Abacus - December 1st, 2019
- Is Nature vs. Nurture an Outdated Concept? - The National Interest Online - December 1st, 2019
- Collection of genetic data leads to privacy concerns - The New Economy - December 1st, 2019
- Is sexual orientation genetic? Yes and no, an extensive study finds - Haaretz - November 19th, 2019
- Sexual orientation cannot be changed at will, lawyers argue - The Straits Times - November 19th, 2019
- Adam and Eve Are Possible: A Second Bite at the Genetic Apple - Christianheadlines.com - November 19th, 2019
- InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and... - November 19th, 2019
- How maternal Zika infection results in newborn microcephaly - Baylor College of Medicine News - November 19th, 2019
- Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform - Endpoints News - November 19th, 2019
- Sexual orientation cannot be wilfully changed, say lawyers fighting to repeal Section 377A - The Straits Times - November 19th, 2019
- The American Heart Association's Annual Conference Comes to Philly This Weekend - Philadelphia magazine - November 19th, 2019
- Clear link between genetics and depressive symptoms uncovered - The Age - November 19th, 2019
- At-Home DNA Tests Still Need the 'Human Touch,' Say Panelists at Genomics Roundtable Workshop - National Academies of Sciences, Engineering, and... - November 19th, 2019
- How in utero Zika virus infection can lead to microcephaly in newborns: Baylor research - Outbreak News Today - November 19th, 2019
- Taller People have Increased Risk of Irregular Heartbeat - News18 - November 19th, 2019
- Alector Reports Recent Business Highlights and Third Quarter 2019 Financial Results - GlobeNewswire - November 19th, 2019
- One of the World's Greatest Geneticists, He Gave Up British Citizenship for India - The Better India - November 19th, 2019
- Section 377A constitutional challenge: Expert evidence reveal sexual orientation cannot be changed at will, lawyers argue - The Online Citizen - November 19th, 2019
- Co-creator of CRISPR lectures about future applications of genome editing technology - Daily Bruin - November 19th, 2019
- Connecting gene mutations, rare genetic diseases - Baylor College of Medicine News - October 28th, 2019
- Utah researchers discover link between certain brain cells and anxiety, OCD - KSL.com - October 28th, 2019
- UH Receives $2M to Study Cancer Risks of Environmental Toxins - Big Island Now - October 28th, 2019
- Genetic testing could keep you healthy. But what about personal info? - Deseret News - October 28th, 2019
- Student group works to foster diversity in the sciences - UChicago News - October 28th, 2019
- Takeaways from ASHG 2019 in Houston: Users of Bionano's Saphyr System Presented Validation Results for FSHD, Repeat Expansion Disorders and Digital... - October 28th, 2019
- DNA research holds the keys to human history but it's being weaponized by politicians - Haaretz - October 28th, 2019
- Scientists have created the first-ever 18-carbon ring, a major feat of molecular architecture - Massive Science - October 28th, 2019
- Law, Privacy and Genome Human Rights Failure in Russia - Putin's Fascination with Hitler's Eugenics Project - Communal News - October 28th, 2019